06.15.2016
Clinical Alerts
05.11.2016
Cystic Fibrosis: New therapies developed
Cystic fibrosis is a life-limiting genetic disorder that affects several body systems including the lung (bronchiectasis), pancreas (malabsorption), liver (biliary cirrhosis), and sweat glands (heat...
05.11.2016
Opioids/Chronic Substance Abuse Disorder
The Center to Advance Palliative Care (CAPC) is a national organization dedicated to increasing the availability of quality palliative services for people facing serious illness....
04.12.2016
Association of Proton Pump Inhibitors with Risk of Dementia
Proton pump inhibitors (PPIs) are widely used for the treatment of gastrointestinal diseases but have also been associated with cognitive decline. Gomm and colleagues performed...
04.12.2016
Antipsychotics and Mortality Risk in Parkinson’s Disease
Of patients with Parkinson’s disease (PD), 60% experience psychosis and 80% develop dementia. The use of antipsychotics to manage symptoms in this population is common. ...
03.07.2016
Management of Diabetes in Long-term Care and Skilled Nursing Facilities
The American Diabetes Association (ADA) recently published a position statement on the management of diabetes at end of life and in those receiving palliative and...
03.07.2016
Study: Hospice Visits in the Last 2 Days of Life
A recent JAMA Internal Medicine study reports that many hospice patients are not visited by a health care professional or social worker in the last...
02.09.2016
Qualitative Study Exploring Palliative Care Medicines
Patients with life-limiting illnesses often have more than one co-morbid condition thereby exacerbating polypharmacy and the continuation of unnecessary medications. Todd and colleagues used in-depth...
01.21.2016
Responding to Suffering
In a recent JAMA article, physicians Epstein and Back implore us to recognize that diagnosing and treating symptoms and illness is only a part of...